Physician profile
Mark G Glaude
NPI 1205045093
$561.96
in general payments reported to CMS, 2019-2025
20 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $122 · 2022: $54.87 · 2023: $57.38 · 2024: $77.93 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $385.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $94.14 | 2025 | |
| Merck Sharp & Dohme LLC | $53.92 | 2024-2025 | Keytruda, Lynparza |
| Endomagnetics LTD | $37.67 | 2021 | |
| W. L. Gore & Associates, INC. | $35.49 | 2021 | |
| Alexion Pharmaceuticals, INC. | $35.18 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $33.29 | 2021-2024 | Myrisk |
| Hologic Sales and Service, LLC | $27.72 | 2025 | Magtrace, Sentimag, Trident Specimen Radiography System |
| Ambu INC. | $27.15 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $23.57 | 2025 | Libtayo |
| Medtronic, INC. | $22.99 | 2023 | |
| Innovation Technologies INC | $21.51 | 2023 | Irrisept |
| Elucent Medical | $19.99 | 2025 | |
| Smith+Nephew, INC. | $19.70 | 2024 | Collagenase Santyl |
| Davol INC. | $19.09 | 2025 | Phasix Mesh |
| Solventum Corporation | $18.28 | 2025 | V.A.C. Dermatac, V.A.C. Veraflo |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $17.71 | 2021 | |
| Boston Scientific Corporation | $15.41 | 2024 | Spyglass Discover |
| Convatec INC. | $14.12 | 2025 | |
| Bard Peripheral Vascular, INC. | $12.88 | 2023 | Rotarexs 6 F X 135 Cm |
| Lemaitre Vascular, INC. | $12.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Glaude listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.